News

Deribit Expands Offers with Innovative BTC and ETH Linear Options

Deribit Expands Offers with Innovative BTC and ETH Linear Options

Deribit Launches New Linear Options for BTC and ETH

This launch reinforces Deribit's commitment to innovation in the trading space.

Deribit, recognized as a premier exchange for digital assets derivatives, has exciting news to share with its users and the broader crypto community. The platform recently unveiled new linear options contracts for Bitcoin (BTC) and Ethereum (ETH), which are priced and settled using USDC. This launch emphasizes Deribit’s ongoing dedication to meeting the evolving needs of its customers.

The introduction of these linear options follows a highly successful rollout of similar contracts for various altcoins over the past year, demonstrating a growing trust in USDC-settled products. Users are now able to hedge their positions or engage in speculative trading with greater accuracy and transparency due to these new offerings. Additionally, the combination of USDC-settled futures alongside the existing perpetual futures has been well-received, reflecting market demand for diverse trading instruments.

Deribit’s CEO, Luuk Strijers, shared insights about the new product launch, noting that “the introduction of linear options for BTC and ETH is an important step in making advanced trading tools available to both institutional and retail clients.” By enabling trading that settles in USDC, Deribit enhances the usability and appeal of its products in a market that is continuously evolving.

Linear options are derivatives that directly correlate with the underlying asset’s market price, adjusting payouts in real-time. Such a mechanism allows traders predictable exposure to price fluctuations, making these options useful for various strategies, including hedging risks or enhancing overall portfolio yield. These instruments are gaining traction as they provide a balanced approach to trading and investing.

Importantly, Deribit assures its users that the newly launched linear options will not disrupt the existing inverse options already available on the platform. In fact, the incorporation of linear options will work seamlessly alongside inverse options, optimizing capital efficiency for users managing different trading positions. With lower minimum order sizes—0.01 BTC and 0.1 ETH—traders can more easily access these new products.

Key Features of the New Linear Options

As traders explore the benefits of these newly introduced linear options, several features highlight their innovative nature. Users can expect greater flexibility from the products, as they cater to a wide range of trading styles—from conservative hedging to aggressive speculative strategies. The options are designed with user demands in mind, reflecting a significant evolution in trading derivatives.

Increased Access and Enhanced Efficiency

Deribit's focus on accessibility is apparent in this launch. The smaller minimum order sizes enable more participants to engage with derivatives trading, irrespective of their capital size. This move promotes greater participation and democratizes access to essential trading instruments.

Robust Infrastructure to Support Trading

Deribit's platform boasts an advanced infrastructure that enhances user experience by allowing for real-time price discovery and low latency trading. This sophistication is crucial, especially for traders participating in rapid market movements. Liquidity is bolstered through collaborations with top-tier market makers, ensuring that trades are executed seamlessly.

About Deribit

Deribit operates as a centralized, institutional-grade exchange specializing in crypto derivatives for options and futures trading. Located in the UAE, the exchange has gained a solid reputation in the market by empowering users with reliable trading solutions and advanced risk management tools. Backed by a team with extensive experience in trading across various markets, Deribit has achieved a leading position in the crypto options trading sphere.

Furthermore, as a subsidiary of Coinbase (NASDAQ: COIN), Deribit benefits from the robust support and innovative spirit of one of the most recognized names in the cryptocurrency world. Coinbase’s mission aligns closely with Deribit’s vision of expanding economic freedom globally, making this partnership especially promising for the future of trading in the coin space.

Frequently Asked Questions

What are linear options, and how do they differ from inverse options?

Linear options adjust payouts in direct proportion to the price of the underlying asset, while inverse options are settled in the asset itself, which can introduce different market dynamics.

Why is Deribit launching USDC-settled options now?

The decision to launch USDC-settled options reflects market demand for products that offer stability and ease of use, especially in a rapidly changing crypto landscape.

How will these new options enhance trading strategies?

These options provide predictable exposure to price movements, allowing traders to implement a broader range of strategies, from hedging to yield enhancement.

What are the minimum order sizes for the new options?

The minimum order size for the new linear options is set at 0.01 BTC and 0.1 ETH, making these options more accessible to a wider audience of traders.

Is there any integration with existing trading features?

Yes, the new linear options are fully integrated with Deribit's existing platform, allowing users to manage both linear and inverse options efficiently.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading